1
Published 2021
Canadian Agency for Drugs and Technologies in Health
...Von Willebrand factor (Recombinant) (Vonvendi) (Shire Pharma Canada ULC, now part of Takeda Canada...

3
Published 2015
Canadian Agency for Drugs and Technologies in Health
... in the upper part of the GI tract often presents with hematemesis (i.e., vomiting of blood or coffee-ground...

4
Published 2015
Canadian Agency for Drugs and Technologies in Health
... in order to be sold can be part of efforts to address prescription drug abuse. The purpose of this review...

5
Published 2015
Canadian Agency for Drugs and Technologies in Health
... in order to be sold can be part of efforts to address prescription drug abuse. The purpose of this review...

6
by Clark, Michelle, Ford, Caitlyn
Published 2019
Canadian Agency for Drugs and Technologies in Health
...This topic was identified as part of CADTH's Horizon Scanning Service for an early assessment...

7
by Clark, Michelle, Ford, Caitlyn
Published 2019
Canadian Agency for Drugs and Technologies in Health
...This topic was identified as part of CADTH's Horizon Scanning Service for an early assessment...

8
by Brett, Kendra, Dulong, Camille, Severn, Melissa
Published 2020
Canadian Agency for Drugs and Technologies in Health
... regarding interventions for the identification of TB. This report is part of series of evidence reviews...

9
Published 2017
Canadian Agency for Drugs and Technologies in Health
.... Antiplatelet therapeutics have become an integral part of this management approach to prevent activation...

10
Published 2017
Canadian Agency for Drugs and Technologies in Health
.... Antiplatelet therapeutics have become an integral part of this management approach to prevent activation...

11
by Brett, Kendra, Dulong, Camille, Severn, Melissa
Published 2020
Canadian Agency for Drugs and Technologies in Health
... regarding interventions for the identification of TB. This report is part of series of evidence reviews...

12
by Brett, Kendra, Dulong, Camille, Severn, Melissa
Published 2020
Canadian Agency for Drugs and Technologies in Health
...This report is part of series of evidence reviews on TB guidelines and can serve as a guidance...

13
by Pohar, Ron, Farrah, Kelly
Published 2019
Canadian Agency for Drugs and Technologies in Health
...When human tissue is removed as part of a medical procedure, the tissue may then be sent to a...

14
by Brett, Kendra, Dulong, Camille, Severn, Melissa
Published 2020
Canadian Agency for Drugs and Technologies in Health
...This report is part of series of evidence reviews on TB guidelines and can serve as a guidance...

15
Published 2015
Canadian Agency for Drugs and Technologies in Health
... as part of bismuth-containing quadruple therapy (BCQT) in the treatment of H. pylori infection. Finally...

16
by Pohar, Ron, Farrah, Kelly
Published 2019
Canadian Agency for Drugs and Technologies in Health
...When human tissue is removed as part of a medical procedure, the tissue may then be sent to a...

17
Published 2019
Canadian Agency for Drugs and Technologies in Health
...-cell lymphoma, and DLBCL arising from follicular lymphoma. As part of CADTH's health technology...

18
Published 2014
Canadian Agency for Drugs and Technologies in Health
... and transmission tomography in 1950, has been a major part of nuclear medicine and has proved to be a valuable non...

19
Published 2019
Canadian Agency for Drugs and Technologies in Health
...-cell lymphoma, and DLBCL arising from follicular lymphoma. As part of CADTH's health technology...

20
Published 2019
CADTH
... to assess different considerations. For its part, this report provides the results of three distinct yet...